\
&
Contact us
\
&
Contact us
This was 6 years ago
LocationKoninklijke Vlaamse Academie van België voor Wetenschappen en Kunsten
Hertogsstraat 1
1000 Brussel
This symposium is part of the 2018 Thinkers' programme on ‘Flanders, Belgium and CERN’ led by Walter Van Doninck (former Vice President of the CERN Council and Thinker-in-Residence).
CERN is a role model for international scientific research in Europe and beyond. This symposium will offer both a general introduction to CERN as well as a Belgian and Flemish perspective. What is the legacy of CERN for mankind? What is its scientific and industrial return for Belgium? What discoveries and technological improvements await in the future? National and international scientists reflect during the symposium resulting from the KVAB Thinkers' Programme "Flanders, Belgium and CERN" with Walter Van Doninck.
The programme, recordings and presentations can be found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
